InfuSystem Holdings, Inc
For the period ended Mar 31, 2025. Filed May 8, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 8, 2025
INFU$15.28+4.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
-Unaudited Condensed Consolidated Balance Sheets as of and
CONDENSED CONSOLIDATED BALANCE SHEETS
| As of | ||
|---|---|---|
| (in thousands, except par value and share data) | March 31, 2025 | December 31, 2024 |
| ASSETS | ||
| Current assets: | ||
| Cash and cash equivalents | $1,506 | $527 |
| Accounts receivable, net | 23,892 | 21,155 |
| Inventories, net | 6,095 | 6,528 |
| Other current assets | 3,829 | 3,955 |
| Total current assets | 35,322 | 32,165 |
| Medical equipment for sale or rental | 2,763 | 3,157 |
| Medical equipment in rental service, net of accumulated depreciation | 38,615 | 39,175 |
| Property & equipment, net of accumulated depreciation | 3,922 | 4,030 |
| Goodwill | 3,710 | 3,710 |
| Intangible assets, net | 6,208 | 6,456 |
| Operating lease right of use assets | 5,244 | 5,374 |
| Deferred income taxes | 6,749 | 7,188 |
| Derivative financial instruments | 1,152 | 1,481 |
| Other assets | 597 | 878 |
| Total assets | $104,282 | $103,614 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $8,367 | $9,848 |
| Other current liabilities | 7,602 | 7,813 |
| Total current liabilities | 15,969 | 17,661 |
| Long-term debt | 28,707 | 23,864 |
| Operating lease liabilities, net of current portion | 4,458 | 4,560 |
| Total liabilities | 49,134 | 46,085 |
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value: authorized 1,000,000 shares; none issued | — | — |
| Common stock, $0.0001 par value: authorized 200,000,000 shares; 20,973,616 shares issued and outstanding as of March 31, 2025 and 21,272,351 shares issued and outstanding as of December 31, 2024 | 2 | 2 |
| Additional paid-in capital | 114,898 | 113,868 |
| Accumulated other comprehensive income | 870 | 1,119 |
| Retained deficit | (60,622) | (57,460) |
| Total stockholders’ equity | 55,148 | 57,529 |
| Total liabilities and stockholders’ equity | $104,282 | $103,614 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.